This clinical trial evaluates a golf recreational exercise program for enhancing survivorship in underrepresented prostate cancer survivors. Golf is a multimodal recreational activity that requires participants to utilize all muscle groups to perform the golf swing, walk over hilly and uneven terrain, maintain balance during putting and squat-like tasks. Physical activity and exercise are beneficial to physical function, cognitive function, psychosocial health, and overall quality of life during prostate cancer survivorship. These aspects of health are impacted by prostate cancer treatment, especially androgen deprivation therapy. Additionally, supervised, group-based activity programs facilitate participation in physical activity. Researchers want to examine the changes in functional abilities, psychosocial health, and quality of life following participation in in a golf program designed for prostate cancer survivors.
First time, primary diagnosis of prostate cancer (PCa)
Currently receiving androgen deprivation therapy (ADT) and/or androgen receptor blocker) for more than 6 months
Older adult male: 55-85 years old
The ability to stand independently without external support
Second cancer diagnosis (excluding non-invasive skin cancers) or bone metastases
Prostatectomy less than 6 months prior to study enrollment (prostatectomy is not a requirement for study entry)
Symptomatic cardiovascular disease, active angina, uncontrolled hypertension (systolic blood pressure (SBP) > 160 or diastolic blood pressure (DBP) > 90, high resting pulse heart rate (HR) > 90), symptomatic orthostatic hypotension
Unstable asthma, exacerbated chronic obstructive pulmonary disease (COPD]
University of Southern California
Lead sponsor
National Cancer Institute (NCI)
Collaborator